0001428500-13-000002.txt : 20130617
0001428500-13-000002.hdr.sgml : 20130617
20130617162701
ACCESSION NUMBER: 0001428500-13-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20130617
DATE AS OF CHANGE: 20130617
EFFECTIVENESS DATE: 20130617
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-198133
FILM NUMBER: 13917079
BUSINESS ADDRESS:
STREET 1: 8001 ARISTA PLACE
STREET 2: SUITE 430
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 8001 ARISTA PLACE
STREET 2: SUITE 430
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
D
1
primary_doc.xml
X0706
D
LIVE
0000907654
ARCA biopharma, Inc.
8001 ARISTA PLACE
SUITE 430
BROOMFIELD
CO
COLORADO
80021
720-940-2200
DELAWARE
NUVELO INC
HYSEQ INC
Corporation
true
Michael
R.
Bristow
8001 Arista Place, Suite 430
Broomfield
CO
COLORADO
80021
Executive Officer
Director
Patrick
M.
Wheeler
8001 Arista Place, Suite 430
Broomfield
CO
COLORADO
80021
Executive Officer
Christopher
D.
Ozeroff
8001 Arista Place, Suite 430
Broomfield
CO
COLORADO
80021
Executive Officer
Jean-Francois
Formela
8001 Arista Place, Suite 430
Broomfield
CO
COLORADO
80021
Director
Linda
Grais
8001 Arista Place, Suite 430
Broomfield
CO
COLORADO
80021
Director
John
L.
Zabriskie
8001 Arista Place, Suite 430
Broomfield
CO
COLORADO
80021
Director
Pharmaceuticals
Decline to Disclose
- 06
false
2013-06-04
false
true
true
false
0
1250000
1250000
0
Assumes the exercise of warrants to purchase 625,000 shares of the Issuer's common stock at an exercise price of $2.00 per share.
false
2
0
0
0
true
false
ARCA biopharma, Inc.
/s/ Michael R. Bristow
Michael R. Bristow
President & CEO
2013-06-17